Liquidia Corporation (NASDAQ:LQDA – Get Free Report) CEO Roger Jeffs sold 25,000 shares of Liquidia stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $56.29, for a total value of $1,407,250.00. Following the completion of the sale, the chief executive officer owned 1,248,095 shares of the company’s stock, valued at $70,255,267.55. This trade represents a 1.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Roger Jeffs also recently made the following trade(s):
- On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $57.04, for a total value of $1,426,000.00.
- On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $41.50, for a total value of $1,037,500.00.
- On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $42.09, for a total value of $1,052,250.00.
- On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.10, for a total value of $1,002,500.00.
- On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total value of $764,863.40.
- On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total value of $1,003,500.00.
- On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total value of $132,000.00.
- On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total transaction of $1,256,387.28.
- On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $859,891.96.
- On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $1,003,000.00.
Liquidia Trading Down 4.0%
LQDA traded down $2.37 during trading on Friday, hitting $56.93. 2,143,237 shares of the company’s stock were exchanged, compared to its average volume of 1,717,407. The company has a current ratio of 2.22, a quick ratio of 1.84 and a debt-to-equity ratio of 1.18. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $59.75. The stock has a 50 day moving average price of $39.25 and a 200 day moving average price of $35.80. The firm has a market cap of $5.06 billion, a P/E ratio of 406.67 and a beta of 0.41.
Hedge Funds Weigh In On Liquidia
Institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Liquidia in the 4th quarter valued at approximately $25,000. Covestor Ltd raised its position in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after purchasing an additional 359 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Liquidia in the 3rd quarter valued at approximately $30,000. FNY Investment Advisers LLC acquired a new position in shares of Liquidia in the 3rd quarter valued at approximately $34,000. Finally, NewEdge Advisors LLC acquired a new position in shares of Liquidia in the 2nd quarter valued at approximately $25,000. 64.54% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages have commented on LQDA. Lifesci Capital upgraded Liquidia to a “strong-buy” rating in a research note on Thursday, March 5th. Jefferies Financial Group reiterated a “buy” rating and issued a $60.00 target price on shares of Liquidia in a research note on Monday. Needham & Company LLC raised their target price on Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a report on Monday. Wall Street Zen raised Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Finally, BTIG Research increased their price objective on shares of Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Monday. Three research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Liquidia presently has a consensus rating of “Moderate Buy” and an average target price of $49.33.
Check Out Our Latest Stock Report on LQDA
More Liquidia News
Here are the key news stories impacting Liquidia this week:
- Positive Sentiment: Liquidia’s first-quarter results beat Wall Street expectations on both earnings and revenue, reinforcing confidence that YUTREPIA is gaining commercial traction and that profitability is improving. Results: Liquidia Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
- Positive Sentiment: Several analysts raised estimates and price targets after the earnings report, including HC Wainwright boosting near-term EPS forecasts and keeping a Buy rating with a $67 target, which supports the bullish outlook on LQDA. Liquidia (LQDA) price target increased by 22.37% to 63.24
- Positive Sentiment: Valuation-focused commentary highlighted that YUTREPIA-driven profitability and strong first-quarter performance could justify Liquidia’s recent share price strength if launch momentum continues. A Look At Liquidia (LQDA) Valuation After YUTREPIA Fueled Profitability And Strong First Quarter Results
- Positive Sentiment: Zacks noted improving earnings estimate revisions, suggesting analysts see additional upside potential for Liquidia in the near term. Earnings Estimates Moving Higher for Liquidia Corporation (LQDA): Time to Buy?
- Neutral Sentiment: Director Stephen Bloch sold 318,893 shares, a notable insider transaction, but it does not necessarily signal a change in the company’s operating outlook. Stephen Bloch Sells 318,893 Shares of Liquidia (NASDAQ:LQDA) Stock
- Neutral Sentiment: One analyst lowered a longer-dated EPS estimate, showing there is still some disagreement on how quickly growth can scale over time. Liquidia stock and analyst reports
About Liquidia
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Further Reading
- Five stocks we like better than Liquidia
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.
